[Microbial sensitivity to ambazone (Faringosept) in pharyngeal samples from patients with acute infections of the upper respiratory tract].
Fulga
Ion
I
UMF Carol Davila Bucureşti, Catedra de farmacologie.
Neguţ
Marian
M
Năşcuţiu
Alexandra-Maria
AM
Nemet
Codruţa
C
Toma
Felicia
F
Grigore
Laura
L
Niţescu
Ruxandra
R
Marcu
Cătălin
C
Nedelcu
Laurenţiu
L
Spircu
Tiberiu
T
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001431:Bacteriological Techniques; D002176:Candida albicans / Q000187:drug effects; D005260:Female; D006193:Haemophilus influenzae / Q000187:drug effects; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D008935:Mitoguazone / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D010612:Pharyngitis / Q000188:drug therapy / Q000382:microbiology; D010614:Pharynx / Q000382:microbiology*; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology*; D012383:Romania; D013211:Staphylococcus aureus / Q000187:drug effects; D013297:Streptococcus pyogenes / Q000187:drug effects
D000890:Anti-Infective Agents; C037931:1,4-benzoquinone guanylhydrazone thiosemicarbazone; D008935:Mitoguazone